tiprankstipranks
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market
Want to see SE:SYNACT full AI Analyst Report?

SynAct Pharma AB (SYNACT) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
SynAct Pharma AB’s (SYNACT) Moving Averages Convergence Divergence (MACD) indicator is 1.17, suggesting SynAct Pharma AB is a Sell.
SynAct Pharma AB’s (SYNACT) 20-Day exponential moving average is 16.20, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Buy.
SynAct Pharma AB’s (SYNACT) 50-Day exponential moving average is 15.85, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Buy.

SynAct Pharma AB (SYNACT) Pivot Points

Jul 06, 2026, 01:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.25
17.29
17.91
18.95
19.57
20.61
21.23
Fibonacci
17.29
17.93
18.32
18.95
19.59
19.98
20.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SynAct Pharma AB (SYNACT) Moving Averages

Jul 06, 2026, 01:06 AM
Period
Simple
Exponential
MA5
19.34Sell
18.60Buy
MA10
17.26Buy
17.44Buy
MA20
15.12Buy
16.20Buy
MA50
15.33Buy
15.85Buy
MA100
16.76Buy
16.78Buy
MA200
19.26Sell
18.39Buy
SynAct Pharma AB’s (SYNACT) 10-Day exponential moving average is 17.44, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Buy.
SynAct Pharma AB’s (SYNACT) 100-Day exponential moving average is 16.78, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Buy.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 50-day simple moving average is 15.33, creating a Buy signal.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 100-day simple moving average is 16.76, creating a Buy signal.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 200-day simple moving average is 19.26, creating a Sell signal.

SynAct Pharma AB (SYNACT) Technical Indicators

Jul 06, 2026, 01:06 AM
Name
Value
Implied Action
RSI (14)
61.62
Neutral
STOCH (9,6)
67.11
Neutral
STOCHRSI (14)
79.19
Neutral
MACD (12,26)
1.17
Sell
ADX (14)
26.30
Neutral
Williams %R
-21.91
Buy
CCI (14)
120.51
Sell
ATR (14)
1.92
-
Ultimate Oscillator
57.27
Neutral
ROC
30.48
Buy
SynAct Pharma AB’s (SYNACT) Relative Strength Index (RSI) is 61.62, creating a Neutral signal.
SynAct Pharma AB’s (SYNACT) Trend Strength Indicator (ADX) is 26.30, creating a Neutral signal.
SynAct Pharma AB’s (SYNACT) Commodity Channel Index (CCI) is 120.51, creating a Sell signal.
SynAct Pharma AB’s (SYNACT) Price Rate of Change (ROC) is 30.48, creating a Buy signal.

FAQ

Is SYNACT a Buy, Hold, or Sell?
Based on SYNACT’s technical indicators, SYNACT is a Buy.
    What is SYNACT’s RSI (14)?
    SYNACT’s RSI (14) is 61.62, which suggests SYNACT is a Neutral.
      What is SYNACT’s MACD?
      SYNACT’s MACD is 1.17, which suggests SYNACT is a Sell.
        What is SYNACT’s 5-day moving average?
        SYNACT’s 5-day moving average is 19.34, which suggests SYNACT is a Sell.
          What is SYNACT’s 20-day moving average?
          SYNACT 20-day moving average is 15.12, which suggests SYNACT is a Buy.
            What is SYNACT’s 50-day moving average?
            SYNACT’s 50-day moving average is 15.33, which suggests SYNACT is a Buy.
              What is SYNACT’s 200-day moving average?
              SYNACT’s 200-day moving average is 19.26, which suggests SYNACT is a Sell.
                What is SYNACT’s Williams % R (14)?
                SYNACT’s Williams % R (14) is -21.91, which suggests SYNACT is a Buy.
                  What is SYNACT’s CCI (14)?
                  SYNACT’s CCI (14) is 120.51, which suggests SYNACT is a Sell.
                    What is the share price of SynAct Pharma AB?